Moderna's COVID-19 vaccine received full approval from the U.S. Food and Drug Administration (FDA) on Monday.
The vaccine, named Spikevax, is approved for use in people ages 18 and older.
Spikevax meets the FDA's rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3